Cargando…

CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker

Microenvironment plays a crucial role in tumor development and progression. Cancer cells modulate the tumor microenvironment, which also contribute to resistance to therapy. Identifying biomarkers involved in tumorigenesis and cancer progression represents a great challenge for cancer diagnosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landras, Alexandra, Reger de Moura, Coralie, Jouenne, Fanelie, Lebbe, Celeste, Menashi, Suzanne, Mourah, Samia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896083/ https://www.ncbi.nlm.nih.gov/pubmed/31744072 http://dx.doi.org/10.3390/cancers11111803

Ejemplares similares

CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1
por: Reger de Moura, Coralie, et al.
Publicado: (2021)

Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance
por: Reger de Moura, Coralie, et al.
Publicado: (2020)

EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
por: Lescaille, Géraldine, et al.
Publicado: (2012)

TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro
por: Delyon, Julie, et al.
Publicado: (2023)

Atypical BRAF and NRAS Mutations in Mucosal Melanoma
por: Dumaz, Nicolas, et al.
Publicado: (2019)

Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care
por: Louveau, Baptiste, et al.
Publicado: (2019)

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma
por: Reger de Moura, Coralie, et al.
Publicado: (2019)

EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF
por: Khayati, Farah, et al.
Publicado: (2015)

A Reliable Method for the Selection of Exploitable Melanoma Archival Paraffin Embedded Tissues for Transcript Biomarker Profiling
por: Lebbe, Celeste, et al.
Publicado: (2012)

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors
por: Louveau, Baptiste, et al.
Publicado: (2019)

Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis
por: Jouenne, Fanélie, et al.
Publicado: (2020)

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma
por: Tétu, Pauline, et al.
Publicado: (2020)

EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2
por: Bougatef, Faten, et al.
Publicado: (2010)

A Novel Case of Gorlin Syndrome Mosaicism Involving an SMO Gene Mutation: Clinical, Histological and Molecular Analysis of Basaloid Tumours
por: IGHILAHRIZ, Meriem, et al.
Publicado: (2021)

A novel tumor suppressor function of Kindlin-3 in solid cancer
por: Djaafri, Ibtissem, et al.
Publicado: (2014)

Platelet-derived growth factor B induces senescence and transformation in normal human fibroblasts
por: Vindrieux, David, et al.
Publicado: (2013)

CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
por: Peng, Fei, et al.
Publicado: (2017)

Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
por: Han, Jang Mi, et al.
Publicado: (2022)

CD147 expression lacks prognostic relevance in esophageal cancer
por: Küsters, Natalie, et al.
Publicado: (2022)

CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance
por: Bakhtiyari, Maryam, et al.
Publicado: (2023)

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
por: Łacina, Piotr, et al.
Publicado: (2022)

CD147 overexpression may serve as a promising diagnostic and prognostic marker for gastric cancer: evidence from original research and literature
por: Hu, Chenghao, et al.
Publicado: (2017)

Spongionella Secondary Metabolites, Promising Modulators of Immune Response through CD147 Receptor Modulation
por: Sánchez, Jon Andoni, et al.
Publicado: (2016)

The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis
por: Li, Hui, et al.
Publicado: (2017)

Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy
por: Delagreverie, Héloïse M, et al.
Publicado: (2020)

Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147)
por: Sehirli, Ahmet Ozer, et al.
Publicado: (2020)

Dealing with the family: CD147 interactions with cyclophilins
por: Yurchenko, Vyacheslav, et al.
Publicado: (2006)

The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview
por: Barillari, Giovanni, et al.
Publicado: (2022)

Expression of Concern: The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis
Publicado: (2023)

Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas
por: Paule, Bernard, et al.
Publicado: (2010)

Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor
por: Louveau, Baptiste, et al.
Publicado: (2017)

CD147 reinforces [Ca(2+)](i) oscillations and promotes oncogenic progression in hepatocellular carcinoma
por: Tang, Juan, et al.
Publicado: (2015)

Deficiency of CD147 Attenuated Non-alcoholic Steatohepatitis Progression in an NLRP3-Dependent Manner
por: Zhang, Tian, et al.
Publicado: (2020)

CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression
por: Cui, Hong-Yong, et al.
Publicado: (2021)

TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Cheng, Sheng, et al.
Publicado: (2023)

The Roles of CD147 and/or Cyclophilin A in Kidney Diseases
por: Qu, Xin, et al.
Publicado: (2014)

Role of MMP-2 and CD147 in kidney fibrosis
por: Cheng, Zhengyuan, et al.
Publicado: (2022)

Role of CD147 in the development and diagnosis of hepatocellular carcinoma
por: Huang, Defa, et al.
Publicado: (2023)

Melanoma Risk and Melanocyte Biology
por: BERTRAND, Juliette U., et al.
Publicado: (2020)

Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
por: Bovenzi, Cory D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_onqfkjhjns3aemb2gnik5epnln